메뉴 건너뛰기




Volumn 371, Issue 22, 2014, Pages 2072-2082

Inactivating mutations in NPC1L1 and protection from coronary heart disease

(77)  Stitziel, Nathan O a   Won, Hong Hee b,c,d   Morrison, Alanna C f   Peloso, Gina M b,c,d   Do, Ron b,c,d   Lange, Leslie A h   Fontanillas, Pierre d   Gupta, Namrata d   Duga, Stefano j   Goel, Anuj m   Farrall, Martin m   Saleheen, Danish r,s   Ferrario, Paola t   König, Inke t   Asselta, Rosanna j   Merlini, Piera A k,l   Marziliano, Nicola k   Notarangelo, Maria Francesca k   Schick, Ursula aa   Auer, Paul ac   more..


Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; NPC1L1 PROTEIN, HUMAN; TRIACYLGLYCEROL;

EID: 84915819121     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1405386     Document Type: Article
Times cited : (377)

References (38)
  • 1
    • 20444371945 scopus 로고    scopus 로고
    • The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)
    • Garcia-Calvo M, Lisnock J, Bull HG, et al. The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci U S A 2005;102:8132-7.
    • (2005) Proc Natl Acad Sci U S A , vol.102 , pp. 8132-8137
    • Garcia-Calvo, M.1    Lisnock, J.2    Bull, H.G.3
  • 2
    • 4043124013 scopus 로고    scopus 로고
    • Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of wholebody cholesterol homeostasis
    • Davis HR Jr, Zhu LJ, Hoos LM, et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of wholebody cholesterol homeostasis. J Biol Chem 2004;279:33586-92.
    • (2004) J Biol Chem , vol.279 , pp. 33586-33592
    • Davis, H.R.1    Zhu, L.J.2    Hoos, L.M.3
  • 3
    • 10744221008 scopus 로고    scopus 로고
    • Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption
    • Altmann SW, Davis HR Jr, Zhu LJ, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004;303:1201-4.
    • (2004) Science , vol.303 , pp. 1201-1204
    • Altmann, S.W.1    Davis, H.R.2    Zhu, L.J.3
  • 4
    • 0037044454 scopus 로고    scopus 로고
    • Inhibition of intestinal cholesterol absorption by ezetimibe in humans
    • Sudhop T, Lütjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002;106:1943-8.
    • (2002) Circulation , vol.106 , pp. 1943-1948
    • Sudhop, T.1    Lütjohann, D.2    Kodal, A.3
  • 5
    • 0034865917 scopus 로고    scopus 로고
    • The plasma concentration and LDL-C relationship in patients receiving ezetimibe
    • Ezzet F, Wexler D, Statkevich P, et al. The plasma concentration and LDL-C relationship in patients receiving ezetimibe. J Clin Pharmacol 2001;41:943-9.
    • (2001) J Clin Pharmacol , vol.41 , pp. 943-949
    • Ezzet, F.1    Wexler, D.2    Statkevich, P.3
  • 6
    • 41649107358 scopus 로고    scopus 로고
    • Simvastatin with or without ezetimibe in familial hypercholesterolemia
    • Erratum, N Engl J Med 2008;358:1977
    • Kastelein JJ, Akdim F, Stroes ES, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008;358:1431-43. [Erratum, N Engl J Med 2008;358:1977.]
    • (2008) N Engl J Med , vol.358 , pp. 1431-1443
    • Kastelein, J.J.1    Akdim, F.2    Stroes, E.S.3
  • 7
    • 33645103550 scopus 로고    scopus 로고
    • Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
    • Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006; 354:1264-72.
    • (2006) N Engl J Med , vol.354 , pp. 1264-1272
    • Cohen, J.C.1    Boerwinkle, E.2    Mosley, T.H.3    Hobbs, H.H.4
  • 9
    • 77955505564 scopus 로고    scopus 로고
    • Biological, clinical and population relevance of 95 loci for blood lipids
    • Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-13.
    • (2010) Nature , vol.466 , pp. 707-713
    • Teslovich, T.M.1    Musunuru, K.2    Smith, A.V.3
  • 10
    • 0026794668 scopus 로고
    • The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences
    • Krawczak M, Reiss J, Cooper DN. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 1992;90:41-54.
    • (1992) Hum Genet , vol.90 , pp. 41-54
    • Krawczak, M.1    Reiss, J.2    Cooper, D.N.3
  • 11
    • 84915795753 scopus 로고    scopus 로고
    • Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction
    • in press
    • Do R, Stitziel NO, Won H-H, et al. Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction. Nature (in press).
    • Nature
    • Do, R.1    Stitziel, N.O.2    Won, H.-H.3
  • 12
    • 0037418247 scopus 로고    scopus 로고
    • No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age
    • Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 2003; 107:1117-22.
    • (2003) Circulation , vol.107 , pp. 1117-1122
  • 13
    • 34249996115 scopus 로고    scopus 로고
    • A common allele on chromosome 9 associated with coronary heart disease
    • McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-91.
    • (2007) Science , vol.316 , pp. 1488-1491
    • McPherson, R.1    Pertsemlidis, A.2    Kavaslar, N.3
  • 14
    • 73549097512 scopus 로고    scopus 로고
    • Genetic variants associated with Lp(a) lipoprotein level and coronary disease
    • Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009;361:2518-28.
    • (2009) N Engl J Med , vol.361 , pp. 2518-2528
    • Clarke, R.1    Peden, J.F.2    Hopewell, J.C.3
  • 15
    • 67349163739 scopus 로고    scopus 로고
    • The Pakistan Risk of Myocardial Infarction Study: A resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia
    • Saleheen D, Zaidi M, Rasheed A, et al. The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia. Eur J Epidemiol 2009;24:329-38.
    • (2009) Eur J Epidemiol , vol.24 , pp. 329-338
    • Saleheen, D.1    Zaidi, M.2    Rasheed, A.3
  • 16
    • 0035094480 scopus 로고    scopus 로고
    • Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs
    • Sentí M, Tomás M, Marrugat J, Elosua R. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs. Arterioscler Thromb Vasc Biol 2001;21:415-20.
    • (2001) Arterioscler Thromb Vasc Biol , vol.21 , pp. 415-420
    • Sentí, M.1    Tomás, M.2    Marrugat, J.3    Elosua, R.4
  • 17
    • 84903727023 scopus 로고    scopus 로고
    • Loss-of-function mutations in APOC3, triglycerides, and coronary disease
    • Crosby J, Peloso GM, Auer PL, et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med 2014;371:22-31.
    • (2014) N Engl J Med , vol.371 , pp. 22-31
    • Crosby, J.1    Peloso, G.M.2    Auer, P.L.3
  • 18
    • 0024591825 scopus 로고
    • The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives
    • The ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702.
    • (1989) Am J Epidemiol , vol.129 , pp. 687-702
    • The ARIC investigators1
  • 19
    • 29244447128 scopus 로고    scopus 로고
    • The Jackson Heart Study: An overview
    • Taylor HA Jr. The Jackson Heart Study: an overview. Ethn Dis 2005;15:Suppl 6: S6-1-S6-3.
    • (2005) Ethn Dis , vol.15 , pp. S61-S63
    • Taylor, H.A.1
  • 20
    • 49949093313 scopus 로고    scopus 로고
    • Development of a large-scale de-identified DNA biobank to enable personalized medicine
    • Roden DM, Pulley JM, Basford MA, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008;84: 362-9.
    • (2008) Clin Pharmacol Ther , vol.84 , pp. 362-369
    • Roden, D.M.1    Pulley, J.M.2    Basford, M.A.3
  • 21
    • 10644262362 scopus 로고    scopus 로고
    • Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: A Go-DARTS study
    • Doney AS, Fischer B, Leese G, Morris AD, Palmer CN. Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler Thromb Vasc Biol 2004;24: 2403-7.
    • (2004) Arterioscler Thromb Vasc Biol , vol.24 , pp. 2403-2407
    • Doney, A.S.1    Fischer, B.2    Leese, G.3    Morris, A.D.4    Palmer, C.N.5
  • 22
    • 84890557979 scopus 로고    scopus 로고
    • Dysfunctional nitric oxide signalling increases risk of myocardial infarction
    • Erdmann J, Stark K, Esslinger UB, et al. Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature 2013;504:432-6.
    • (2013) Nature , vol.504 , pp. 432-436
    • Erdmann, J.1    Stark, K.2    Esslinger, U.B.3
  • 23
    • 84915817665 scopus 로고    scopus 로고
    • An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease
    • Ye Z, Kalloo FS, Dalenberg AK, Kullo IJ. An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease. Glob Cardiol Sci Pract 2013;2013:82-90.
    • (2013) Glob Cardiol Sci Pract , vol.2013 , pp. 82-90
    • Ye, Z.1    Kalloo, F.S.2    Dalenberg, A.K.3    Kullo, I.J.4
  • 24
    • 39749089905 scopus 로고    scopus 로고
    • Rationale, design, and methodology of the Women's Genome Health Study: A genome-wide association study of more than 25,000 initially healthy American women
    • Ridker PM, Chasman DI, Zee RY, et al. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy American women. Clin Chem 2008;54:249-55.
    • (2008) Clin Chem , vol.54 , pp. 249-255
    • Ridker, P.M.1    Chasman, D.I.2    Zee, R.Y.3
  • 25
    • 6844255857 scopus 로고    scopus 로고
    • Design of the Women's Health Initiative clinical trial and observational study
    • The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
    • (1998) Control Clin Trials , vol.19 , pp. 61-109
  • 26
    • 78449281377 scopus 로고    scopus 로고
    • Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials
    • Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376: 1670-81.
    • (2010) Lancet , vol.376 , pp. 1670-1681
    • Baigent, C.1    Blackwell, L.2    Emberson, J.3
  • 27
    • 77953699732 scopus 로고    scopus 로고
    • NPC1L1 and cholesterol transport
    • Betters JL, Yu L. NPC1L1 and cholesterol transport. FEBS Lett 2010;584:2740-7.
    • (2010) FEBS Lett , vol.584 , pp. 2740-2747
    • Betters, J.L.1    Yu, L.2
  • 28
    • 78650191019 scopus 로고    scopus 로고
    • Emphasizing the burden of proof: The American College of Cardiology 2008 expert panel comments on the ENHANCE Trial
    • Krumholz HM. Emphasizing the burden of proof: the American College of Cardiology 2008 Expert Panel Comments on the ENHANCE Trial. Circ Cardiovasc Qual Outcomes 2010;3:565-7.
    • (2010) Circ Cardiovasc Qual Outcomes , vol.3 , pp. 565-567
    • Krumholz, H.M.1
  • 29
    • 50949102416 scopus 로고    scopus 로고
    • Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
    • Cannon CP, Giugliano RP, Blazing MA, et al. Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J 2008;156:826-32.
    • (2008) Am Heart J , vol.156 , pp. 826-832
    • Cannon, C.P.1    Giugliano, R.P.2    Blazing, M.A.3
  • 30
    • 84913596368 scopus 로고    scopus 로고
    • APOC3, coronary disease, and complexities of Mendelian randomization
    • Cohen JC, Stender S, Hobbs HH. APOC3, coronary disease, and complexities of Mendelian randomization. Cell Metab 2014;20:387-9.
    • (2014) Cell Metab , vol.20 , pp. 387-389
    • Cohen, J.C.1    Stender, S.2    Hobbs, H.H.3
  • 31
    • 32444441330 scopus 로고    scopus 로고
    • Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels
    • Cohen JC, Pertsemlidis A, Fahmi S, et al. Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci U S A 2006; 103:1810-5.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , pp. 1810-1815
    • Cohen, J.C.1    Pertsemlidis, A.2    Fahmi, S.3
  • 32
    • 46249103255 scopus 로고    scopus 로고
    • Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes
    • Fahmi S, Yang C, Esmail S, Hobbs HH, Cohen JC. Functional characterization of genetic variants in NPC1L1 supports the sequencing extremes strategy to identify complex trait genes. Hum Mol Genet 2008;17:2101-7.
    • (2008) Hum Mol Genet , vol.17 , pp. 2101-2107
    • Fahmi, S.1    Yang, C.2    Esmail, S.3    Hobbs, H.H.4    Cohen, J.C.5
  • 33
    • 17744390348 scopus 로고    scopus 로고
    • Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters
    • Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000;290:1771-5.
    • (2000) Science , vol.290 , pp. 1771-1775
    • Berge, K.E.1    Tian, H.2    Graf, G.A.3
  • 34
    • 50549083074 scopus 로고    scopus 로고
    • Curses - Winner's and otherwise - In genetic epidemiology
    • Kraft P. Curses - winner's and otherwise - in genetic epidemiology. Epidemiology 2008;19:649-51.
    • (2008) Epidemiology , vol.19 , pp. 649-651
    • Kraft, P.1
  • 35
    • 84899476119 scopus 로고    scopus 로고
    • Guidelines for investigating causality of sequence variants in human disease
    • MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature 2014;508:469-76.
    • (2014) Nature , vol.508 , pp. 469-476
    • MacArthur, D.G.1    Manolio, T.A.2    Dimmock, D.P.3
  • 36
    • 24144438622 scopus 로고    scopus 로고
    • NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe
    • Hegele RA, Guy J, Ban MR, Wang J. NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe. Lipids Health Dis 2005;4:16.
    • (2005) Lipids Health Dis , vol.4 , pp. 16
    • Hegele, R.A.1    Guy, J.2    Ban, M.R.3    Wang, J.4
  • 37
    • 14244262377 scopus 로고    scopus 로고
    • Compound heterozygosity for two nonsynonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe
    • Wang J, Williams CM, Hegele RA. Compound heterozygosity for two nonsynonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe. Clin Genet 2005;67:175-7.
    • (2005) Clin Genet , vol.67 , pp. 175-177
    • Wang, J.1    Williams, C.M.2    Hegele, R.A.3
  • 38
    • 84893378179 scopus 로고    scopus 로고
    • Searching for missing heritability: Designing rare variant association studies
    • Zuk O, Schaffner SF, Samocha K, et al. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci U S A 2014;111:E455-64.
    • (2014) Proc Natl Acad Sci U S a , vol.111 , pp. E455-E464
    • Zuk, O.1    Schaffner, S.F.2    Samocha, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.